Purpose
to assess AlphaSeq as an approach to discover and optimize broadly cross-reactive biologics against infectious diseases prevalent in developing countries.
Grantee
Division
Global Health
Date
APRIL 2019
Region served
GLOBAL
Committed amount
$68,653
Grant topic
Support Innovative Technology Solutions
Duration (months)
6
Grantee location
Seattle, Washington, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.